International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

Ko Jenny J.; Xie Wanling; Kroeger Nils; Lee Jae-Lyun; Rini Brian I.; Knox Jennifer J.; Bjarnason Georg A.; Srinivas Sandy; Pal Sumanta K.; Yuasa Takeshi; Smoragiewicz Martin; Donskov Frede; Kanesvaran Ravindran; Wood Lori; Ernst D. Scott; Agarwal Neeraj; Vaishampayan Ulka N.; Rha Sun-young; Choueiri Toni K.; Heng Daniel Y. C.

首页> 外文期刊>The lancet oncology >International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

【24h】

International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

机译：国际转移性肾细胞癌数据库联合会模型作为先前接受过一线靶向治疗的转移性肾细胞癌患者的预后工具：一项基于人群的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Previous prognostic models for second-line systemic therapy in patients with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving next-line targeted therapy after progression on first-line targeted therapy.

机译：背景技术先前针对转移性肾细胞癌患者进行二线全身治疗的预后模型尚未在靶向治疗的背景下进行研究。我们试图验证国际转移性肾细胞癌数据库联盟（IMDC）模型在转移性肾细胞癌患者接受一线靶向治疗后接受下一线靶向治疗的情况。

著录项

来源
《The lancet oncology》 |2015年第3期|共8页
作者
Ko Jenny J.; Xie Wanling; Kroeger Nils; Lee Jae-Lyun; Rini Brian I.; Knox Jennifer J.; Bjarnason Georg A.; Srinivas Sandy; Pal Sumanta K.; Yuasa Takeshi; Smoragiewicz Martin; Donskov Frede; Kanesvaran Ravindran; Wood Lori; Ernst D. Scott; Agarwal Neeraj; Vaishampayan Ulka N.; Rha Sun-young; Choueiri Toni K.; Heng Daniel Y. C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study [J] . Ko Jenny J., Xie Wanling, Kroeger Nils, The lancet oncology . 2015,第3期

机译：国际转移性肾细胞癌数据库联合会模型作为先前接受过一线靶向治疗的转移性肾细胞癌患者的预后工具：一项基于人群的研究
2. Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study [J] . Perez-Valderrama B., Arranz Arija J. A., Rodriguez Sanchez A., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第4期

机译：国际转移性肾细胞癌数据库联合会（IMDC）对转移性肾癌中的一线帕唑帕尼预后模型的验证：西班牙肿瘤泌尿生殖系统研究小组（SOGUG）SPAZO研究
3. Re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8 The Change in Baseline IMDC Prognostic Category: From the Past, Implications for the Future [J] . Iacovelli Roberto, Artibani Walter, Tortora Giampaolo European urology . 2017,第6期

机译：Re：Ian D. Davis，Wanling谢，Carmel Pezaro，等。二线靶向治疗对肾细胞癌的疗效根据国际转移性肾细胞癌数据库联盟的基线变化。 EUR UROL 2017; 71：970-8基线IMDC预后类别的变化：从过去，对未来的影响
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
6. Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry [O] . Jung Kwon Kim, Sung Han Kim, Mi Kyung Song, 2019

机译：国际转移性肾细胞癌数据库联盟和纪念斯隆·凯特琳癌症中心风险模型在转移性非透明细胞肾细胞癌患者中的应用：使用韩国转移性肾细胞癌注册中心的多机构回顾性研究
7. First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium [O] . Shaan Dudani, Jeffrey Graham, J. Connor Wells, 2019

机译：转移性肾细胞癌中的一线免疫肿瘤组合疗法：国际转移性肾细胞癌数据库联盟的结果

International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

摘要

著录项

相似文献

相关主题

期刊订阅